Moreover, the presence of signaling pathways related to inflammatory cytokines, such as TNF and IL-17, among the top ranked target-associated pathways highlighted the significant impact of inflammation on bone metabolism in postmenopausal osteoporosis [36]. The gene discussed is IL17A; the disease is postmenopausal osteoporosis.